Interleukin 12: Basic biology and potential applications in cancer treatment

Oncologist

Volumn 1, Issue 1-2, 1996, Pages 88-97

  Robertson, Michael J ^a   Ritz, Jerome ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Antitumor immunity; Biologic therapy; Cytokine therapy; Immunotherapy; Interleukin 12 (IL 12); Tumor immunology

Indexed keywords

EID: 0002325617     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.1-1-88     Document Type: Article

References (18)

1. Kobayashi M, Fitz L, Ryan M et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989;170:827-845.
2. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
3. Stern AS, Podlaski FJ, Hulmes JD et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-Iymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-6812.
4. Gubler U, Chua AO, Schoenhaut DA et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991;88:4143-4147.
5. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-4027.
6. Wolf SF, Sieburth D, Sypek J. Interleukin 12: a key modulator of immune function. STEM CELLS 1994;12:154-168.
7. Hendrzak JA, Brunda MJ. Interleukin-12: biologic activity, therapeutic utility, and role in disease. Lab Invest 1995;72:619-637.
8. Brunda MJ, Gately MK. Interleukin-12: potential role in cancer therapy. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology 1995. Philadelphia: J. B. Lippincott, 1995:3-18.
9. Schoenhaut DS, Chua AO, Wolitzky AG et al. Cloning and expression of murine IL-12. J Immunol 1992;148:3433-3440.
10. Gearing DP, Cosman D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 1991;66:9-10.
11. Merberg DM, Wolf SF, Clark SC. Sequence similarity between NKSF and the IL-6/G-CSF family. Immunol Today 1992;13:77-78.
12. Chizzonite R, Truitt T, Desai BB et al. IL-12 receptor: I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. J Immunol 1992;148:3117-3124.
13. Desai BB, Quinn PM, Wolitzky AG et al. IL-12 receptor: II. Distribution and regulation of receptor expression. J Immunol 1992;148:3125-3132.
14. Naume B, Gately MK, Desai BB et al. Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine 1993;5:38-46.
15. Chua AO, Chizzonite R, Desai BB et al. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 1994;153:128-136.
16. Pignata C, Sanghera JS, Cossette L et al. Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells. Blood 1994;83:184-190.
17. Pignata C, Prasad KVS, Hallek M et al. Phosphorylation of srcfamily lck tyrosine kinase following interleukin-12 activation of human natural killer cells. Cell Immunol 1995;165:211-216.
18. Ihle JN, Witthuhn BA, Quelle FW et al. Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 1995;13:369-398.